glp 1 drugs for perimenopause Let’s talk about GLP-1 medications in the context of and menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity, GLP-1 Agonists in Perimenopause: Unique

danuglipron and lotiglipron were discontinued in development due to hepatotoxicity signals, underscoring safety considerations unique to this drug class

Chronic poor sleep (less than 7-8 hours per night for most adults) and high stress levels can increase the production of the stress hormone cortisol

7 Figure 3 provides a simplified summary of the decision cycle

Appetite Regulation GLP-1 receptor agonists influence the brains appetite centers, leading to a reduction in hunger and cravings

Related Links: Stopping your GLP-1

At the same time as these investigations were happening, similar work was being undertaken by Ole Dragsbk Madsen, a Danish scientist working thirty minutes away at Novo Nordisk's Hagedorn Research Institute